Back to Search Start Over

U.K. approves CRISPR therapy for sickle cell.

Source :
Science. 11/24/2023, Vol. 382 Issue 6673, p862-862. 2/3p. 1 Color Photograph.
Publication Year :
2023

Abstract

The article reports that the United Kingdom has approved a groundbreaking CRISPR therapy developed by Vertex Pharmaceuticals and CRISPR Therapeutics, utilizing gene editing to treat sickle cell and beta thalassemia, demonstrating significant success in clinical trials.

Subjects

Subjects :
*CRISPRS
*CELLULAR therapy
*SICKLE cell anemia
*ERYTHROCYTES
*FETAL hemoglobin
*BETA-Thalassemia

Details

Language :
English
ISSN :
00368075
Volume :
382
Issue :
6673
Database :
Academic Search Index
Journal :
Science
Publication Type :
Academic Journal
Accession number :
173796692

Tools

Authors Abstract Subjects Details